维药蜀葵花化学成分的分离与鉴定(Ⅱ)

目的对维药蜀葵花(Althaea rosea(Linn.)Cavan.)的化学成分进行进一步的研究。方法采用正相硅胶、反相ODS、Sephadex LH-20等柱色谱及高效液相色谱手段进行分离纯化,并通过理化性质与波谱分析方法鉴定化合物的化学结构。结果从蜀葵花体积分数为95%的乙醇提取物中分离得到9个黄酮类单体成分,分别鉴定为槲皮素(quercetin,1)、槲皮素-3-O-β-D-吡喃葡萄糖苷(quercetin-3-O-β-D-glucopyranoside,2)、槲皮素-3-O-(6″-O-反式对香豆酰基)-β-D-吡喃葡萄糖苷(quercetin-3-O-(6″-O-trans-p-coumaroyl)-β-D-glucopyranoside,3)、槲皮素-3-O-芸香糖苷(quercetin 3-O-rutinoside,4)、槲皮素-7-O-β-D-吡喃葡萄糖苷(quercetin-7-O-β-D-glucopyranoside,5)、槲皮素-4'-O-β-D-吡喃葡萄糖苷(quercetin 4'-O-β-D-glucopyranoside,6)、槲皮素-3'-甲氧基-3-O-芸香糖苷(quercetin 3'-methoxy-3-O-β-D-rutinoside,7)、杨梅素-3-O-β-D-吡喃葡萄糖苷(myricetin-3-O-β-D-glucopyranoside,8)和芹菜素-4'-O-β-D-吡喃葡萄糖苷(apigenin-4'-O-β-D-glucopyranoside,9)。结论化合物3、7、9为首次从蜀葵属中分离得到,化合物6为首次从蜀葵花中分离得到。     

齿叶白鹃梅叶中黄酮类成分的分离与结构鉴定

目的研究齿叶白鹃梅叶的化学成分。方法采用硅胶柱色谱、重结晶和Sephadex LH-20凝胶柱色谱的方法进行化学成分的分离和纯化,根据化合物的理化性质和波谱数据鉴定其结构。结果分离得到6个黄酮类化合物,经鉴定为芹菜素(apigenin1,),木犀草素(luteolin,2),槲皮素(querce-tin,3),槲皮素-3-O-β-D-葡萄糖苷(quercetin-3-O-β-D-glucopyranoside,4),芹菜素-7-O-β-D-葡萄糖苷(apigenin-7-O-β-D-glucopyranoside,5),芹菜素-7-O-β-D-新橙皮糖苷(apigenin-7-O-β-D-neosphero-side,6)。结论化合物1-6均首次从此植物中分离得到。     

沙生蜡菊花中黄酮类成分的分离与鉴定

目的研究沙生蜡菊(Helichrysum arenarium(L.)Moench)花的化学成分。方法采用硅胶柱色谱?ODS柱色谱和HPLC柱色谱分离纯化,依据理化性质、波谱数据分析进行结构鉴定。结果从沙生蜡菊花的甲醇提取物中分离得到8个黄酮类化合物,分别鉴定为山奈酚3-O-β-D-吡喃葡萄糖苷(kaempferol 3-O-β-D-glucopyranoside,1)、木犀草素3′-O-β-D-吡喃葡萄糖苷(luteolin3′-O-β-D-glucopyranoside,2)、木犀草素7-O-β-D-吡喃葡萄糖苷(luteolin7-O-β-D-glucopyranoside,3)、木犀草素6-羟基-7-O-β-D-吡喃葡萄糖苷(luteolin6-hydroxy-7-O-β-D-glucopyranoside,4)、木犀草素3′-甲氧基-6-羟基-7-O-β-D-吡喃葡萄糖苷(luteolin3′-methoxyl-6-hydroxy-7-O-β-D-glucopyranoside,5)、黄芩素7-O-β-D-吡喃葡萄糖苷(scutellarein7-O-β-D-glucopyranoside,6)、山柰酚3-O-β-D-龙胆二糖苷(kaempferol3-gentiobioside,7)、山柰酚3-O-(3-β-D-吡喃葡萄糖基)-β-D-吡喃葡萄糖苷(kaempferol3-O-(3-β-D-glucopyranosyl)-β-D-glucopyranoside,8)。结论化合物2、4~8为首次从蜡菊属植物中分离得到。     

桃儿七中黄酮类成分的分离与鉴定

目的对桃儿七的95%(φ)乙醇提取物的化学成分进行研究。方法利用反复硅胶、SephadexLH-20、开放ODS柱色谱等方法进行分离纯化;根据理化性质及波谱分析对分离得到的化合物进行结构鉴定。结果分离得到8个黄酮类化合物,分别鉴定为山柰酚(kaempferol,1)、槲皮素(querce-tin,2)、杨梅素-3',4'-二甲醚(myricetin-3',4'-dimethyl ether,3)、3-O-甲基-槲皮素(3-O-methyl-quercetin,4)、山柰酚-3-O-β-D-葡萄糖苷(kaempferol-3-O-β-D-glucopyranoside,5)、槲皮素-3-O-β-D-葡萄糖苷(quercetin-3-O-β-D-glucopyranoside,6)、芦丁(rutin,7)、山柰酚-3-O-芸香糖苷(kaempfer-ol-3-O-rutinoside,8)。结论化合物3、4、8为首次从该属植物中分离得到。     

火绒草黄酮类成分的分离与鉴定(Ⅱ)

目的对火绒草的化学成分进行研究,为进一步开发利用该植物资源提供依据。方法采用反复正相硅胶、反相ODS、Sephadex LH-20等柱色谱以及高效液相色谱法等手段进行分离纯化,并通过理化性质与光谱分析鉴定化合物的结构。结果从火绒草体积分数为70%的乙醇溶液提取物中又分离鉴定了7个黄酮类化合物,分别为芹菜素(apigenin,1)、山柰酚-3-O-(6″-O-乙酰基)-β-D-吡喃葡萄糖苷[kaempferol-3-O-(6″-O-acetyl)-β-D-glucopyranoside,2]、山柰酚-3-O-(6″-O-反式对香豆酰基)-β-D-吡喃葡萄糖苷[kaempferol-3-O-(6″-O-trans-p-coumaroyl)-β-D-glucopyranoside,3]、山柰酚-3-O-(6″-O-顺式对香豆酰基)-β-D-吡喃葡萄糖苷[kaempferol-3-O-(6″-O-cis-p-coumaroyl)-β-D-glucopyranoside,4]、槲皮素-7-O-β-D-吡喃葡萄糖苷(quercetin-7-O-β-D-glucopyranoside,5)、槲皮素-3-甲氧基-7-O-β-D-吡喃葡萄糖苷(quercetin-3-me-thoxy-7-O-β-D-glucopyranoside,6)、槲皮万寿菊素-7-O-β-D-吡喃葡萄糖苷(quercetagetin-7-O-β-D-glucopyranoside,7)。结论化合物1为首次从火绒草植物中分离得到,化合物2～7为首次从火绒草属植物中分离得到。     

中药黄蜀葵花化学成分的分离与鉴定(Ⅰ)

目的研究中药黄蜀葵(Abelmoschus manihot(L.)Medic.)花的化学成分,为进一步开发利用该植物资源提供依据。方法采用反复硅胶柱色谱、反相ODS、Sephadex LH-20等柱色谱以及高效液相色谱等手段进行分离纯化,并通过理化性质与波谱数据鉴定了化合物的结构。结果分离得到7个以杨梅素为母核的黄酮类化合物,分别鉴定为杨梅素(myricetin,1)、杨梅素-3-O-β-D-葡萄糖苷(myricetin-3-O-β-D-glucopyranoside,2)、cannabiscitrin(3)、杨梅素-3-O-β-D-半乳糖苷(myricetin-O-β-D-galactopyranoside,4)、杨梅素-3-O-芸香糖苷(myricetin-3-O-rutinose,5)、杨梅素-3-O-刺槐糖苷(myricetin-3-O-robinoside,6)、myricetin-3-O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranoside(7)。结论化合物4～7为秋葵属植物中首次分离得到。     

中药黄蜀葵花化学成分的分离与鉴定(Ⅱ)

目的研究中药黄蜀葵(Abelmoschus manihot(L.)Medic.)花的化学成分,为进一步开发利用该植物资源提供依据。方法采用正相硅胶、反相ODS、Sephadex LH-20等柱色谱以及高效液相色谱等手段进行分离纯化,并通过理化性质与光谱分析鉴定化合物的结构。结果从黄蜀葵花体积分数为95%的乙醇提取物的大孔吸附树脂洗脱物中分离鉴定了9个以槲皮素为母核的黄酮类化合物,分别为槲皮素(quercetin,1)、金丝桃苷(hyperoside,2)、槲皮素-3-O-β-D-葡萄糖苷(quercetin-3-O-β-D-glucopyranoside,3)、槲皮素-3-O-β-D-6″-乙酰葡萄糖苷(quercetin-3-O-β-D-6″-acetylglucopyr-anoside,4)、槲皮素-3-O-刺槐糖苷(quercetin-3-O-robinoside,5)、槲皮素-3-O-芸香糖苷(quercetin-3-O-rutinoside,6)、槲皮素-3-O-β-D-木糖基-(1→2)-β-D-半乳糖苷(quercetin-3-O-β-D-xylopyranosyl(1→2)-β-D-galactopyranoside,7)、槲皮素-3′-O-β-D-葡萄糖苷(quercetin-3′-O-β-D-glucopyranoside,8)以及槲皮素-7-O-β-D-葡萄糖苷(quercetin-7-O-β-D-glucopyranoside,9)。结论化合物4、5、7和9为首次从秋葵属植物中分离得到。     

火绒草中的黄酮苷类成分

目的研究火绒草[Leontopodium leontopodioides(Wild.)Beauv.]中黄酮苷类化学成分。方法采用反复硅胶柱色谱法、Sephadex LH-20柱色谱法、ODS柱色谱法和反复重结晶等方法进行分离纯化,并通过理化常数测定和波谱分析鉴定了其化学结构。结果从体积分数为60%的火绒草乙醇溶液提取物中分离得到5个化合物,并鉴定其结构为:芹菜素-7-O-β-D-吡喃葡萄糖苷(apigenin-7-O-β-D-glu-copyranoside1)、木犀草素-4′-O-β-D-吡喃葡萄糖苷(luteolin-4′-O-β-D-glucopyranoside2)、6-羟基-木犀草素-7-O-β-D-吡喃葡萄糖苷(6-hydroxyluteolin-7-O-β-D-glucopyranoside3)、6-羟基-芹菜素-7-O-β-D-吡喃葡萄糖苷(6-hydroxyapigenin-7-O-β-D-glucopyranoside4)、槲皮素-3-O-β-D-吡喃葡萄糖苷(quercetin-3-O-β-D-glucopyranoside5)。结论化合物4,5为首次从火绒草属植物中分离得到,化合物2,3为首次从本植物火绒草中分离得到。     

中药北刘寄奴中黄酮类成分的分离与鉴定

目的研究中药北刘寄奴(Siphonostegia chinensis Benth.)的化学成分。方法采用正相硅胶、反相ODS、Sephadex LH-20等柱色谱及高效液相色谱等手段进行分离纯化,并通过理化性质与光谱分析方法鉴定了化合物的结构。结果从北刘寄奴体积分数为95%的乙醇提取物中分离鉴定了8个黄酮类单体成分,分别为芹菜素(apigenin,1)、芹菜苷(apigentrin,2)、木犀草素(luteolin,3)、木犀草素-7-O-β-D-葡萄糖苷(luteolin-7-O-β-D-glucopyranoside,4)、槲皮素-3-O-β-D-葡萄糖苷(quer-cetin-3-O-β-D-glucopyranoside,5)、槲皮素-3-O-α-L-鼠李糖苷(quercetin-3-O-α-L-rhamnopyranoside,6)、isoscutellarein 8-glucuronide(7)、大豆素(daidzein,8)。结论其中化合物4～8为首次从阴行草属中分离得到。     

野菊花中的黄酮类化学成分

目的 研究野菊花乙醇提取物中乙酸乙酯层化学成分. 方法 采用硅胶柱色谱、ODS柱色谱、Sephadex LH-20柱色谱和制备液相色谱等手段进行分离、并根据理化性质和光谱数据鉴定化合物结构. 结果 从野菊花中分离得到10种黄酮类化合物,分别鉴定为5, 7, 4’-三羟基-3’, 5’-二甲氧基黄酮 (1)、5, 7, 3’, 4’-四羟基-6, 5’-二甲氧基黄酮(2)、槲皮素(3)、木犀草素(4)、槲皮素-7-O-β-D-葡萄糖(5)、刺槐素-7-O-β-D-葡萄糖(6)、香叶木素-7-O-β-D-葡萄糖苷(7)、木犀草素-7-O-β-D-葡萄糖苷(8)、芹菜素-7-O-β-D-葡萄糖苷(9)、蒙花苷(10). 结论 槲皮素-7-O-β-D-葡萄糖首次从野菊花中分离得到.     

Synthesis and evaluation of 2,6-piperidinedione derivatives as potentially novel compounds with analgesic and other CNS activities

New 2,6-piperidinediones 2_a–g and 4_a–d were prepared by initial condensation of aromatic aldehydes or cycloalkanones with cyanoacetamide to give α-cyanocinnamides l_a–g or cycloalkylidenes 3_a,b which underwent Michae1 addition with ethyl cyanoacetate or diethylmalonate. Compounds 4_a–d were alkylated by various alkyl halides to produce the N-alkylated 2,6-piperidinedione derivatives 5_a–m. Some new selected compounds 2_a–c,f, 4_a–d & 5_e,h,j were pharmacologically evaluated for potential anticonvulsant, sedative and analgesic activities. These compounds exhibited significant anticonvulsant and analgesic effects after a single I.P. administration 100 mg/kg b.wt. . On the other hand all the investigated compounds induced hypnotic activity and prolonged the phenobarbital sodium- induced sleep as compared with the control group and the most potent compound was found to be 2_f.     

EFFECT OF POLICOSANOL SUCCESSIVE DOSE INCREASES ON PLATELET AGGREGATION IN HEALTHY VOLUNTEERS

Policosanol is a cholesterol-lowering drug with hypocholesterolemic effects demonstrated in experimental models, healthy volunteers and type II hypercholesterolemic patients. In addition, antiplatelet effects of policosanol have been shown in experimental models and healthy volunteers. The effect of successively increasing doses of policosanol on platelet aggregation was investigated in a randomized, placebo-controlled, double-blind study conducted in 37 healthy volunteers. The volunteers were on a placebo-baseline period (two tablets per day) for 7 days and thereafter they received randomly, under double-blind conditions, placebo or policosanol (10mgday⁻¹) for 7 days. After this period dosage was doubled to 20mgday⁻¹for the next 7 days and then again doubled to 40mgday⁻¹, while the control group received placebo tablets all the time. Platelet aggregation as well as coagulation time was measured at baseline and after each dosing step. Results showed that antiplatelet effects of policosanol were successfully enhanced throughout the study, thus suggesting a dose-dependent relationship. No significant effect was reached during the first dosing period, but significant reductions of epinephrine and ADP-induced platelet aggregation were observed after the second one. Finally, a significant inhibition of platelet aggregation induced by all the agonists was observed at the last dosing step. Coagulation time remained unchanged during the trial.     

NEURAMIDE STIMULATES ADRENOCORTICOTROPIN BUT NOT PROLACTIN RELEASE FROM RAT PITUITARY

Neuramide (NMD), a substance found in crude preparations of porcine stomach extract, is a viral inhibitor that also has putative immunostimulatory effects. The effects of NMD on stress-hormone (ACTH and prolactin—PRL) release were assessed inin vivoandin vitrostudies. In the former, blood levels of corticosterone and PRL were measured in NMD-treated male rats.In vitroexperiments were performed to evaluate the effects of NMD and three of its fractions (obtained with high performance liquid chromatography) on ACTH and PRL release from perfused rat pituitary slices. NMD increased plasma corticosterone levelsin vivoand produced dose-dependent increases inin vitropituitary release of ACTH. No effects on PRL secretion were observedin vivoorin vitro. The stimulatory effects on ACTH release were caused by the NMD fraction with a molecular weight of >5000<10000Da.     

Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations

In this study, the antibiotic susceptibilities to tigecycline and tetracycline of 35 selected Bacteroides fragilis group strains were determined by Etest, and the presence of tetQ, tetX, tetX1 and ermF genes was investigated by polymerase chain reaction (PCR). tetQ was detected in all 12 B. fragilis group isolates (100%) exhibiting elevated tigecycline minimum inhibitory concentrations (MICs) (≥8 μg/mL) as well as the 8 strains (100%) with a tigecycline MIC of 4 μg/mL, whilst tetX and tetX1 were present in 15% and 75% of these strains, respectively. All of these strains were fully resistant to tetracycline (MIC ≥ 16 μg/mL). On the other hand, amongst the group of strains with tigecycline MICs < 4 μg/mL (15 isolates), tetQ, tetX and tetX1 were found less frequently (73.3%, 13.3% and 46.7%, respectively). All but two strains harbouring the tetQ gene in this group were non-susceptible to tetracycline, with a MIC > 4 μg/mL. These data suggest that in most cases tigecycline overcomes the tetracycline resistance mechanisms frequently observed in Bacteroides strains. However, the presence of tetX and tetX1 genes in some of the strains exhibiting elevated MICs for tigecycline draws attention to the possible development and spread of resistance to this antibiotic agent amongst Bacteroides strains. The common occurrence of ermF, tetX, tetX1 and tetQ genes together predicted the presence of the CTnDOT-like Bacteroides conjugative transposon in this collection of Bacteroides strains.     

鼻渊净胶囊的HPLC指纹图谱研究

目的 建立鼻渊净胶囊的高效液相色谱(HPLC)指纹图谱.方法 采用Agilent SB-C18(4.6 mm×250 mm,5μm)色谱柱,乙腈-水为流动相、以1.0 ml/min流速行梯度洗脱,检测波长210 nm,柱温30℃,洗脱时间为80 min.采用中药色谱指纹图谱相似度评价系统(2004A版)对检测出色谱进行...     

INDIRECT PARASYMPATHOMIMETIC ACTIVITY OF THE CLASS III ANTIARRHYTHMIC SUBSTANCE / -SOTALOLIN VITRO: REVERSIBLE INHIBITION OF CHOLINESTERASE ISOENZYMES FROM BLOOD AND THE HUMAN CENTRAL NERVOUS SYSTEM

Inhibitory effects of the class III antiarrhythmic compound / -sotalol on acetylcholinesterase (AChE; EC 3.1.1.7) isoenzymes of both erythrocytes and the human caudate nucleus and on serum cholinesterase (ChE; EC 3.1.1.8) were studiedin vitrousing a spectrophotometric kinetic assay with acetylthiocholine (ASCh) as substrate. Sotalol concentrations in the assays varied from 0.32 to 3.2m . All isoenzymes studied were inhibited by / -sotalol in a reversible and concentration-dependent manner. Double reciprocal plots of the reaction velocity against varying ASCh concentrations revealed that / -sotalol reduced substrate affinity (apparent Michaelis constant, KM, increased) of serum ChE, but did not change the enzyme's maximal rate of ASCh hydrolysis (V_max). Thus, / -sotalol inhibition of serum ChE was of the competitive type (rate constant for reversible competitive inhibition: K_i=0.51m ). In contrast, / sotalol reduced the maximal reaction velocity of the AChE isoenzyme from the central nervous system (caudate nucleus), but had no influence on substrate affinity of the enzyme (K_Mwith ASCh unchanged) indicating purely non-competitive inhibition kinetics (rate constant of reversible non-competitive inhibition: K_i′=0.44m ). / -sotalol inhibition of erythrocyte AChE was of mixed competitive/non-competitive type (K_i=0.31m , K_i′=0.49m ). Non-competitive / -sotalol inhibition of caudate nucleus AChE and the non-competitive component of erythrocyte AChE inhibition cannot be overcome by increased concentrations of the cholinergic transmitter acetylcholine (ACh). Peak / -sotalol plasma levels as described in the literature for both humans (15μ ) and experimental animals (dogs: 18μ ; rats: 260μ ) as well as maximal myocardial concentrations of the substance (dogs: 46μ ; rats: 478μ ) are in the range of about 2% to 100% of the sotalol inhibition rate constants determined in the present paper for cholinesterase isoenzymesin vitro. Thus, / -sotalol inhibition of ACh hydrolysisin vivomay contribute to both the well known antiarrhythmic potential and proarrhythmic side effects of the compound.     

栝楼不同药用部位质量控制的研究进展

瓜蒌子、瓜蒌皮、瓜蒌、天花粉来源于栝楼的不同药用部位,4味药材均为常用的大宗药材,现行版《中国药典》对其制定的质量标准过于简单,无法科学合理地控制其质量。本文对瓜蒌子、瓜蒌皮、瓜蒌、天花粉安全性和有效组分的研究进行综述,明确了相关研究存在的问题并针对问题提出建议,为科学全面的药材及饮片标准的制定提供参考依据。     

AMELIORIATION OF CHEMICALLY-INDUCED HEPATOCYTE INJURY BY CYCLOSPORINE A

Cyclosporine A, beside its current applications, possesses potential hepatoprotective effects. This study was directed to investigate the effect of Cyclosporine A pretreatment on hepatic injury due to carbon tetrachloride (CCl₄) and -galactosamine. Rats were injected by two successive doses of Cyclosporine A (5mgkg⁻¹day⁻¹). Six hours after the second dose, 1mlkg⁻¹of CCl₄was administered i.p. Effects associated with Cyclosporine A pretreatment were examined by using isolated hepatocytes and hepatocytes that were immobilized and continuously perfused. -Galactosamine (5m ) was added directly to the perfusion medium. After isolation, hepatocytes were examined histologically by light and electron microscopy, immobilized and perfused for further metabolic functional activity evaluation. Cyclosporine A pretreatmentin vivoproduced hepatoameliorative effects of various degrees which were statistically significant as manifested by: (1) an increased trypan blue exclusion after CCl₄; (2) an improved ureagenesis after CCl₄; (3) a reduction in the lipid droplets accumulation in the cytoplasm produced by CCl₄administration; (4) well preserved cytoplasmic organelles as mitochondria, endoplasmic reticulum ER, nuclear chromatin structures that were altered by CCl₄; and (5) an increased hepatocytes survival in the agarose gel matrix, reduction of LD leakage and improvement of ureagenesis after -galactosamine addition to the perfusion medium. The beneficial effect of Cyclosporine A pretreatment in modifying hepatotoxicity of chemical insults merits further studies.     

EFFECTS OF 2-GUANIDINE-4-METHYLQUINAZOLINE ON GASTRIC ACID SECRETION IN RATS

In this study 2-guanidine-4-methylquinazoline (2-GMQ) appeared to decrease basal and stimulated gastric acid secretion, while structurally related compounds as dimethyl- biguanide, cyanoguanidine and 2-cyanoamino-4-methylpyrymidine did not. Thus, there is an antisecretory effect when the biguanide group is associated with a lipophilic structure. The antisecretive effects exerted by 2-GMQ are associated with anti H₂-histamine activity.The anti H₂-histamine nature of the effects of 2-GMQ was confirmed by the capacity of this compound of depressing the chronotropic activity of the isolated guinea pig auricle increased by histamine, as well as relaxant activity in rat uterus contracted by histamine, since both preparations are rich in H₂-histamine receptors.     

Genotyping and in vitro antifungal susceptibility of Neoscytalidium dimidiatum isolates from different origins

This study evaluated the genetic variability and in vitro susceptibility patterns of isolates of Neoscytalidium dimidiatum and Scytalidium hyalinum from different geographical origins. Partial sequences of four loci (the ITS region and D1/D2 domains of the 28S rRNA gene and the tubulin and chitin synthase genes) were analysed. Among a total of 1970 bp sequenced in 24 isolates, 7 polymorphic positions (0.36%) were detected, representing five different sequence types (ST1–ST5), from which two (ST2 and ST3) were detected exclusively in isolates from plants, two (ST1 and ST5) were found only in clinical isolates and one (ST4) was observed in isolates from humans and from a mango tree. We propose subordinating S. hyalinum as a variety of N. dimidiatum. Amphotericin B was the most active drug, but low minimum inhibitory concentrations were also detected for voriconazole, terbinafine and anidulafungin.